Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|April 9, 2011
Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatusAlejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Sílvia Cufí, et al.
Cell Cycle (Georgetown, Tex.)|September 9, 2011
Raptor, a positive regulatory subunit of mTOR complex 1, is a novel phosphoprotein of the rDNA transcription machinery in nucleoli and chromosomal nucleolus organizer regions (NORs)Alejandro Vazquez-Martin, Sílvia Cufí, Cristina Oliveras-Ferraros, et al.
Cell Cycle (Georgetown, Tex.)|June 8, 2012
Polo-like kinase 1 directs the AMPK-mediated activation of myosin regulatory light chain at the cytokinetic cleavage furrow independently of energy balanceAlejandro Vazquez-Martin, Sílvia Cufí, Cristina Oliveras-Ferraros, et al.
Cell Cycle (Georgetown, Tex.)|November 5, 2011
mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and agingJavier A Menendez, Luciano Vellon, Cristina Oliveras-Ferraros, et al.
BMC Cancer|July 10, 2012
Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancerJoana Relat, Adriana Blancafort, Glòria Oliveras, et al.
Cell Cycle (Georgetown, Tex.)|December 1, 2011
Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotypeSílvia Cufí, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.
The Science of the Total Environment|November 3, 2024
Chronological assessment of heuristic data driven approaches for soil water content simulation in subsurface drip irrigated riceJalal Shiri, Mohammad Hossein Kazemi, Sepideh Karimi, et al.
Aging|December 16, 2011
Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancerJavier A Menendez, Sílvia Cufí, Cristina Oliveras-Ferraros, et al.
Cell Cycle (Georgetown, Tex.)|July 20, 2012
Metformin is synthetically lethal with glucose withdrawal in cancer cellsJavier A Menendez, Cristina Oliveras-Ferraros, Sílvia Cufí, et al.
Pageof 4